Haemonetics' President and CEO, Chris Simon, was featured on this week’s episode of Vanguards of Health Care by Bloomberg Intelligence. Listen to Chris discuss the company’s solutions, growth and evolution in the #MedTech industry here: https://bit.ly/3XlBZYn
About us
Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. To learn more about Haemonetics, visit www.haemonetics.com.
- Website
-
http://www.haemonetics.com
External link for Haemonetics
- Industry
- Medical Equipment Manufacturing
- Company size
- 1,001-5,000 employees
- Headquarters
- Boston, MA
- Type
- Public Company
- Founded
- 1971
- Specialties
- Blood collection and separation technologies, surgical blood salvage systems, diagnostic products, software and information technology platforms, consulting services, interventional technologies, and plasma collection products
Locations
-
Primary
Get directions
Boston, MA 02110, US
Employees at Haemonetics
Updates
-
As our interns learn the ins and outs of being part of a global #MedTech organization, they can find ways to apply their existing skills, while building new ones, in a dynamic atmosphere. #MakeItMatter #InternLifeAtHAE
-
-
Primary Immunodeficiency (PID) is a chronic disease, meaning those with it require specific care for the rest of their lives. A common treatment for PID is medicine derived from blood plasma. If you can, consider donating for #ChronicDiseaseAwarenessDay: https://bit.ly/33cPE8f
-
-
Haemonetics' internship program allows students to get hands on experience with real-world projects that help them develop relevant, applicable skills. #MakeItMatter #InternLifeAtHAE
-
-
Haemonetics Sets Date for Publishing First Quarter Fiscal Year 2025 Results: August 8, 2024: https://bit.ly/3S0LUPF
-
Our interns are motivated by the impact Haemonetics' products and solutions can have on patient care. #MakeItMatter #InternLifeAtHAE
-
-
Haemonetics colleagues Lisa Kelly and Vincenzo Leo are enjoying the International Society on Thrombosis and Haemostasis (ISTH) Congress in Bangkok! If you see them, they’ll be happy to answer your questions about Haemonetics’ TEG® 6s system, Global Haemostasis, PlateletMapping® testing and TEG Manager® software. #ISTH2024 #Haemonetics #TEG6s #PlateletMapping #TEGManager #Thrombosis #Haemostasis #PatientCare #HealthcareInnovation #ClinicalExcellence
-
-
Haemonetics Interventional Technologies is hiring! Check out the available positions on our website and apply to join this growing team. #MakeItMatter
Haemonetics is an innovative team looking for top talent! If you’re a Clinical Specialist with a background in electrophysiology or cardiology, check out the variety of positions we have available across the United States. https://hubs.ly/Q02D2xrn0
-
-
Are you attending the International Society of Blood Transfusion (ISBT) Congress in Barcelona 23-27 June, 2024? Join us to explore how our NexSys PCS® and BloodTrack® HaemoBank® solutions can elevate patient safety through streamlined plasma collection and blood management. We look forward to connecting with you at booth D.42. #ISBTBarcelona #ISBT2024 #PatientSafety #PBM #PatientBloodManagement #MakeitMatter #bloodtransfusion
-
Haemonetics Launches Limited Market Release for New VASCADE MVP® XL Vascular Closure Device: https://bit.ly/3ziYIu8
-
Affiliated pages
Similar pages
Browse jobs
Stock
HAE
NYSE
20 minutes delay
$91.55
1.35 (1.497%)
- Open
- 90.54
- Low
- 90.12
- High
- 92.118
Data from Refinitiv
See more info on